The World Health Organization (WHO) has officially certified Denmark for the elimination of mother-to-child transmission (EMTCT) of HIV and syphilis, a landmark achievement that underscores the nation’s decades-long commitment to reproductive health and universal healthcare. This certification recognizes Denmark’s success in ensuring that every child is born free of these life-altering infections, making it the first country within the European Union to reach this specific public health milestone. The validation serves as a testament to the efficacy of the Danish health system, which prioritizes equal access to comprehensive prenatal care, robust diagnostic screening, and immediate treatment interventions for pregnant women.
The official validation was the culmination of a rigorous assessment process conducted by international health experts. In June 2025, the WHO’s Regional Validation Committee evaluated Denmark’s national data and healthcare protocols, followed by a final review by the Global Validation Advisory Committee (GVAC) in August 2025. These committees confirmed that Denmark had consistently met and exceeded all required targets for the period spanning 2021 to 2024. These targets include maintaining extremely low transmission rates and ensuring high coverage of both prenatal testing and treatment for all pregnant women across the country, regardless of their socioeconomic status or origin.
A Rigorous Standard for Public Health Excellence
The elimination of mother-to-child transmission is not defined by the total absence of cases, but rather by the achievement of specific, scientifically grounded benchmarks that indicate the transmission has been reduced to a level where it no longer constitutes a major public health problem. For a country to be validated by the WHO, it must demonstrate that it tests and treats at least 95% of all pregnant women for HIV and syphilis. Furthermore, the rate of new infant infections must be kept below 50 per 100,000 live births consistently over several years.
Denmark’s achievement of these benchmarks is rooted in its highly organized antenatal care system. By integrating HIV and syphilis screening into routine prenatal visits, the Danish healthcare system ensures that infections are identified at the earliest possible stage. Once an infection is detected, the system provides immediate access to antiretroviral therapy (ART) for HIV or penicillin treatment for syphilis. These interventions are highly effective at preventing the pathogens from crossing the placenta or infecting the newborn during childbirth. The success of this "test and treat" model is evidenced by Denmark’s transmission rates, which have effectively dropped to zero in recent years for mother-to-child cases.
Statistical Profile and Epidemiological Context
Denmark’s success is particularly notable when viewed through the lens of its national epidemiological data. The country maintains a low prevalence of HIV and syphilis among its general population, which provides a strong foundation for elimination efforts. According to recent health data, approximately 5,950 people are currently living with HIV in Denmark. Among pregnant women, the prevalence is exceptionally low, affecting less than 0.1% of the population. Through systematic routine testing, the transmission of HIV from mother to child has been virtually eradicated.
The data regarding syphilis further highlights the strength of Denmark’s public health surveillance. In 2024, a total of 626 cases of syphilis were reported nationwide. A detailed breakdown of these figures shows that the infection remains more prevalent among men, who accounted for 524 of the reported cases. In contrast, only 102 cases were reported among women. This disparity, combined with universal prenatal screening, has made congenital syphilis—where the infection is passed from mother to baby—an uncommon occurrence in the country.
Regarding hepatitis B, which is the third component of the WHO’s "triple elimination" goal, Denmark reports a prevalence of chronic infection between 0.2% and 0.3%. These cases are primarily identified among migrant populations from regions where the virus is endemic. Denmark is currently working closely with the WHO to validate the elimination of mother-to-child transmission of hepatitis B as well, aiming for the full triple elimination status in the near future.
The Pillars of Danish Success: Systems, Rights, and Data
The path to this certification was built on several key pillars: a universal health system, a rights-based approach to medical care, and world-class data monitoring. Denmark’s healthcare system is characterized by equal access for all residents, ensuring that financial barriers do not prevent pregnant women from seeking the care they need. This inclusivity is central to the WHO’s criteria for elimination, as it ensures that vulnerable or marginalized groups are not left behind in public health initiatives.
Furthermore, Denmark’s exemplary data systems have been essential for the validation process. The country utilizes robust laboratory networks and comprehensive electronic health records that allow for real-time tracking of screenings, diagnoses, and treatment outcomes. This level of data granularity provides public health officials with the evidence needed to prove that transmission targets are being met consistently across the entire population.
Human rights also play a significant role in Denmark’s strategy. The country emphasizes informed consent, confidentiality, and the empowerment of women in the healthcare process. By fostering a high level of trust between patients and healthcare providers, Denmark has achieved high participation rates in its screening programs, which is a prerequisite for achieving EMTCT.
Official Responses and Global Leadership
The certification has drawn praise from the highest levels of international and national health leadership. Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, remarked that the achievement marks a major public health milestone. He noted that Denmark’s success demonstrates that with strong political commitment and consistent investment in primary care, it is possible to protect every newborn from these diseases. Dr. Tedros emphasized that Denmark serves as a model for how integrated maternal and child health services can deliver life-saving results.
Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, highlighted the significance of Denmark being the first EU country to reach this goal. He praised the strength of the Danish maternal health system and the country’s long-standing commitment to reaching every pregnant woman. Dr. Kluge reiterated that the WHO will continue to support Denmark as it pursues the final step of triple elimination by adding hepatitis B to its list of eliminated transmissions.
From the Danish perspective, Sophie Løhde, the Minister for the Interior and Health, expressed immense pride in the validation. She attributed the success to decades of dedicated work by healthcare professionals, including midwives, doctors, and public health teams. Løhde emphasized that the universal health system, built on the principle of equal access, served as the foundation for this achievement. She also expressed hope that Denmark’s experience would inspire other nations to strengthen their own EMTCT programs.
Global Context and the Road Ahead
Denmark now joins a select group of 22 other countries and territories that have been validated by the WHO for the elimination of mother-to-child transmission of HIV, syphilis, or hepatitis B. This diverse group includes nations from various regions, such as Cuba (the first to be validated in 2015), Thailand, Belarus, Armenia, Malaysia, and several Caribbean islands including Antigua and Barbuda, Belize, and Jamaica. More recently, countries like Botswana and Namibia have also made significant strides in this area, proving that elimination is possible across different economic and geographical contexts.
The inclusion of Denmark in this list is particularly significant for the European region. While many European countries have high standards of care, the formal validation process requires a level of documented consistency and system-wide integration that can be challenging to prove. Denmark’s success provides a roadmap for other EU member states, demonstrating how existing healthcare infrastructure can be optimized to meet global elimination standards.
Looking forward, the Danish health authorities are focused on achieving "triple elimination." This involves adding the hepatitis B virus (HBV) to the current successes with HIV and syphilis. The WHO is actively collaborating with Denmark to advance this process. Achieving triple elimination would represent the ultimate standard in maternal and child health, ensuring that infants are protected against three of the most significant infectious threats during the perinatal period.
Implications for Public Health Policy
The validation of Denmark’s EMTCT program has broader implications for global public health policy. It reinforces the idea that infectious disease control is most effective when integrated into general maternal and child health services rather than managed through siloed programs. By making HIV and syphilis testing a standard part of prenatal care, Denmark has normalized these screenings, reduced stigma, and ensured high uptake.
Moreover, Denmark’s success highlights the importance of the "path to elimination" framework. For countries that have not yet reached the elimination thresholds, the WHO offers a "path to elimination" certification that recognizes high-level progress. Denmark’s journey shows that sustained investment over decades—rather than short-term campaigns—is the key to permanent success.
As the global health community looks toward the 2030 Sustainable Development Goals, which include ending the epidemics of AIDS and other communicable diseases, Denmark’s certification offers a tangible example of progress. It proves that the tools to prevent mother-to-child transmission are available and highly effective; the challenge lies in the political will and systemic organization required to deliver those tools to every woman, every time. Denmark has shown that with a foundation of universal health coverage and a commitment to human rights, the goal of an AIDS-free and syphilis-free generation is not just an aspiration, but a reachable reality.